Likely short candidate MDRNA Inc (ticker: MRNA) is trading right around its 50- and 200-day MA but a recent bump makes me think it's a good time to short. The company has fallen from its loftier $20 share price in 2006 to trade right around a buck. Earning have improved, but they are still far behind industry peers, and even underwent a name change in 2008 (formerly known as Nastech, NSTK), but that hasn't stopped the bleeding. I think this one is circling the drain...

Enter a stock symbol to view that company's Altman Z-Score if it is a manufacturing company, or its Altman Z"-Score, if it is a non-financial, non-manufacturing company, and to view message board posts for that stock (Scores are available for premium members).

Below is a list of today's twenty-five most distressed stocks (according to their Altman Z-Score or Z''-Score, respectively) with a share price of $5 or higher. For details on how this ranking list is compiled, please click here.